Consequently, compared to individual protein molecules, a clinical model based on the combined expression of Ki67, Her-2, and MutP53 proteins might provide a more accurate and comprehensive reflection of CRC progression and prognosis. Here, ERBB2 is linked to colorectal carcinoma.